The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Prostate Cancer Testing-Global Market Insights and Sales Trends 2024
Synopsis
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
The global Prostate Cancer Testing market size is expected to reach US$ 22660 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Testing in various end use industries. The expanding demands from the Hospital Associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes and Others, are propelling Prostate Cancer Testing market. PSA Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTC Tests segment is estimated at % CAGR for the next seven-year period.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Testing covered in this report include Genomic Health, OPKO, Siemens Healthcare, DiaSorin, bioMeriux, Roche, MDx Health, Beckman Coulter and Myriad Genetics, etc.
The global Prostate Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Global Prostate Cancer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Testing market, Segment by Type:
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Global Prostate Cancer Testing market, by Application
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Prostate cancer testing refers to the tests conducted for the detection, localization, grading, and staging of prostate carcinoma. The currently established methods of prostate cancer detection include digital rectal examination (DRE), serum prostate-specific antigen (PSA) tests, and transrectal ultrasound (TRUS)-guided prostate biopsy using a systematic 12-core method.
The global Prostate Cancer Testing market size is expected to reach US$ 22660 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Prostate Cancer Testing in various end use industries. The expanding demands from the Hospital Associated Labs, Independent Diagnostic Laboratories, Cancer Research Institutes and Others, are propelling Prostate Cancer Testing market. PSA Tests, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTC Tests segment is estimated at % CAGR for the next seven-year period.
The high prevalence rate of prostate cancer is a key factor, which is driving the global market for the prostate cancer. Prostate cancer is the second-leading cause of death in the United States. According to National Cancer Institute, it is estimated that there were around 161,360 new cases of prostate cancer and an estimated 26,730 people will die due to it. Based on these statistics, we can see that the prevalence rate of prostate cancer is increasing across the world and hence, it is driving the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Prostate Cancer Testing, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Prostate Cancer Testing market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Prostate Cancer Testing market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Prostate Cancer Testing sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Prostate Cancer Testing covered in this report include Genomic Health, OPKO, Siemens Healthcare, DiaSorin, bioMeriux, Roche, MDx Health, Beckman Coulter and Myriad Genetics, etc.
The global Prostate Cancer Testing market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
Global Prostate Cancer Testing market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Prostate Cancer Testing market, Segment by Type:
PSA Tests
CTC Tests
Immunohistochemistry
PCA3 Tests
Others
Global Prostate Cancer Testing market, by Application
Hospital Associated Labs
Independent Diagnostic Laboratories
Cancer Research Institutes
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Prostate Cancer Testing companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Prostate Cancer Testing
1.1 Prostate Cancer Testing Market Overview
1.1.1 Prostate Cancer Testing Product Scope
1.1.2 Prostate Cancer Testing Market Status and Outlook
1.2 Global Prostate Cancer Testing Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Prostate Cancer Testing Market Size by Region (2018-2029)
1.4 Global Prostate Cancer Testing Historic Market Size by Region (2018-2023)
1.5 Global Prostate Cancer Testing Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Prostate Cancer Testing Market Size (2018-2029)
1.6.1 North America Prostate Cancer Testing Market Size (2018-2029)
1.6.2 Europe Prostate Cancer Testing Market Size (2018-2029)
1.6.3 Asia-Pacific Prostate Cancer Testing Market Size (2018-2029)
1.6.4 Latin America Prostate Cancer Testing Market Size (2018-2029)
1.6.5 Middle East & Africa Prostate Cancer Testing Market Size (2018-2029)
2 Prostate Cancer Testing Market by Type
2.1 Introduction
2.1.1 PSA Tests
2.1.2 CTC Tests
2.1.3 Immunohistochemistry
2.1.4 PCA3 Tests
2.1.5 Others
2.2 Global Prostate Cancer Testing Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Prostate Cancer Testing Historic Market Size by Type (2018-2023)
2.2.2 Global Prostate Cancer Testing Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Prostate Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Prostate Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Prostate Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Prostate Cancer Testing Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Prostate Cancer Testing Revenue Breakdown by Type (2018-2029)
3 Prostate Cancer Testing Market Overview by Application
3.1 Introduction
3.1.1 Hospital Associated Labs
3.1.2 Independent Diagnostic Laboratories
3.1.3 Cancer Research Institutes
3.1.4 Others
3.2 Global Prostate Cancer Testing Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Prostate Cancer Testing Historic Market Size by Application (2018-2023)
3.2.2 Global Prostate Cancer Testing Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Prostate Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Prostate Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Prostate Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Prostate Cancer Testing Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Prostate Cancer Testing Revenue Breakdown by Application (2018-2029)
4 Prostate Cancer Testing Competition Analysis by Players
4.1 Global Prostate Cancer Testing Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Prostate Cancer Testing as of 2022)
4.3 Date of Key Players Enter into Prostate Cancer Testing Market
4.4 Global Top Players Prostate Cancer Testing Headquarters and Area Served
4.5 Key Players Prostate Cancer Testing Product Solution and Service
4.6 Competitive Status
4.6.1 Prostate Cancer Testing Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Genomic Health
5.1.1 Genomic Health Profile
5.1.2 Genomic Health Main Business
5.1.3 Genomic Health Prostate Cancer Testing Products, Services and Solutions
5.1.4 Genomic Health Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.1.5 Genomic Health Recent Developments
5.2 OPKO
5.2.1 OPKO Profile
5.2.2 OPKO Main Business
5.2.3 OPKO Prostate Cancer Testing Products, Services and Solutions
5.2.4 OPKO Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.2.5 OPKO Recent Developments
5.3 Siemens Healthcare
5.3.1 Siemens Healthcare Profile
5.3.2 Siemens Healthcare Main Business
5.3.3 Siemens Healthcare Prostate Cancer Testing Products, Services and Solutions
5.3.4 Siemens Healthcare Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.3.5 DiaSorin Recent Developments
5.4 DiaSorin
5.4.1 DiaSorin Profile
5.4.2 DiaSorin Main Business
5.4.3 DiaSorin Prostate Cancer Testing Products, Services and Solutions
5.4.4 DiaSorin Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.4.5 DiaSorin Recent Developments
5.5 bioMeriux
5.5.1 bioMeriux Profile
5.5.2 bioMeriux Main Business
5.5.3 bioMeriux Prostate Cancer Testing Products, Services and Solutions
5.5.4 bioMeriux Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.5.5 bioMeriux Recent Developments
5.6 Roche
5.6.1 Roche Profile
5.6.2 Roche Main Business
5.6.3 Roche Prostate Cancer Testing Products, Services and Solutions
5.6.4 Roche Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.6.5 Roche Recent Developments
5.7 MDx Health
5.7.1 MDx Health Profile
5.7.2 MDx Health Main Business
5.7.3 MDx Health Prostate Cancer Testing Products, Services and Solutions
5.7.4 MDx Health Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.7.5 MDx Health Recent Developments
5.8 Beckman Coulter
5.8.1 Beckman Coulter Profile
5.8.2 Beckman Coulter Main Business
5.8.3 Beckman Coulter Prostate Cancer Testing Products, Services and Solutions
5.8.4 Beckman Coulter Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.8.5 Beckman Coulter Recent Developments
5.9 Myriad Genetics
5.9.1 Myriad Genetics Profile
5.9.2 Myriad Genetics Main Business
5.9.3 Myriad Genetics Prostate Cancer Testing Products, Services and Solutions
5.9.4 Myriad Genetics Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.9.5 Myriad Genetics Recent Developments
5.10 Ambry Genetics
5.10.1 Ambry Genetics Profile
5.10.2 Ambry Genetics Main Business
5.10.3 Ambry Genetics Prostate Cancer Testing Products, Services and Solutions
5.10.4 Ambry Genetics Prostate Cancer Testing Revenue (US$ Million) & (2018-2023)
5.10.5 Ambry Genetics Recent Developments
6 North America
6.1 North America Prostate Cancer Testing Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Prostate Cancer Testing Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Prostate Cancer Testing Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Prostate Cancer Testing Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Prostate Cancer Testing Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Prostate Cancer Testing Market Dynamics
11.1 Prostate Cancer Testing Industry Trends
11.2 Prostate Cancer Testing Market Drivers
11.3 Prostate Cancer Testing Market Challenges
11.4 Prostate Cancer Testing Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
